Scilex Holding (SCLX) Treasury Shares (2023 - 2026)
Scilex Holding (SCLX) posted quarterly Treasury Shares of $76.9 million for Q1 2026, little changed year-over-year from $76.9 million in Q1 2025, and little changed on a QoQ basis from $76.9 million in Q4 2025.
Scilex Holding (SCLX) Treasury Shares (2023 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Treasury Shares for 4 consecutive years, with $76.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares changed 0.0% year-over-year to $76.9 million; the TTM figure through Mar 2026 stood at $76.9 million (changed 0.0% YoY), while the FY2025 annual figure was $76.9 million, down 15.03% from the prior year.
- Treasury Shares came in at $76.9 million for Q1 2026 at Scilex Holding, roughly flat from $76.9 million in the prior quarter.
- The five-year high for Treasury Shares was $60.1 million in Q3 2023, with the low at $1458.0 in Q1 2025.
- Average Treasury Shares over 4 years is $11.3 million, with a median of $1716.0 recorded in 2023.
- Across the five-year window, Treasury Shares changed 0.0% in 2024 and decreased 15.03% in 2025, its largest moves.
- Year by year, Treasury Shares stood at $90.5 million in 2023, then changed by 0.0% to $90.5 million in 2024, then fell by 15.03% to $76.9 million in 2025, then changed by 0.0% to $76.9 million in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $76.9 million, $76.9 million, and $76.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 3.01 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 76.26 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 10.61 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.11 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 3.94 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | -47.00 Mn |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.92 Mn |
| Mar 31, 2026 | 76.92 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 76.92 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Dec 31, 2025 | 76.92 Mn |
| Sep 30, 2025 | 76.92 Mn |
| Sep 30, 2025 | 76.92 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 76.92 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Jun 30, 2025 | 76.92 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 76.92 Mn |
| Mar 31, 2025 | 1,458.00 |
| Mar 31, 2025 | 1,458.00 |
| Mar 31, 2025 | 76.92 Mn |